4D Molecular Therapeutics Inc
FDMT
$12.36-4.92%
End of day · as of Oct 14, 2026, 2:00 AM ET
Mkt cap
$518.06M
EV/Sales
5.37
P/E ratio
N/A
FY2025 Revenue
$85.21M
EPS (TTM)
$-2.63
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-164.43%
Beta
2.76
Div yield
N/A
Sector
Healthcare
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported FDMT revenue for 2025-12-31 was $85.2M. Net income was -$140.1M. Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. FDMT currently screens at market cap $518.1M.
Use this FDMT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FDMT income, balance, and cash tables.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company in the Healthcare sector.
Latest cached 4D Molecular Therapeutics Inc (FDMT) revenue for Dec 31, 2025 was $85.2M. Net income was -$140.1M. Statements: https://lician.com/financials/fdmt
4D Molecular Therapeutics Inc (FDMT) market capitalization is $518.1M on the latest cached snapshot.
4D Molecular Therapeutics Inc (FDMT) cached previous close $13.00; day range $12.36 – $12.91; volume 991,380. Session quote: https://lician.com/quote/fdmt
4D Molecular Therapeutics Inc (FDMT) latest cached earnings event is "FDMT earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached FDMT filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/fdmt